Clinical Trial Update: A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." [Phase 2]

View source ↗

Summary

Phase 2 open-label multicenter trial evaluating ixazomib, iberdomide, and dexamethasone in elderly patients with multiple myeloma at first relapse; currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• NINLARO (ixazomib)
• iberdomide (iberdomide)

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Myeloma at First Relapse | Phase 2 | Status: ACTIVE_NOT_RECRUITING